Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Vanik A. Ovsepyan"'
Publikováno v:
Blood. 122:4999-4999
Introduction In some cases of the cytogenetic analysis patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) there are increase frequency non-clonal disorders (“cytogenetic noise”) in combination with complex (≥ 3 chromo
Autor:
Rolf Marschalek, Anatoly Kustanovich, Olga Plekhanova, Tatyana Riger, Anna Demina, Yulia Olshanskaya, Olga Kalennik, Alena Volochnik, Claus Meyer, Sokova Oi, Olga Streneva, Egor Shorikov, Tatyana V. Nasedkina, Grigory Tsaur, Irina Shmunk, Margarita Strigaleva, Irina Martynkevich, Alexander Popov, Leonid Saveliev, Tatyana Verzhbitskaya, Vanik A. Ovsepyan, Tatyana Gindina, Larisa Fechina, Elena Fleishman
Publikováno v:
Blood. 120:2537-2537
Abstract 2537 Background. MLL gene rearrangements are the most common genetic events in infant leukemia. Up to date more than 100 various MLL rearrangements were described. Purpose. To evaluate the distribution of MLL rearrangements among infants (ag
Autor:
Lubov Gavrilova, Alexander S. Luchinin, Olga Senderova, Vanik A. Ovsepyan, Marya V. Galayko, Sergey V. Meresy, Valentyna M. Pepelyaeva, Sergey M. Kulikov, Galina I. Milutina, Irina A. Titshenko, L B Avdeeva, Olga Vinogradova, Ekaterina Chelysheva, Eduard G. Gendgan, Anna G. Turkina
Publikováno v:
Blood. 120:4431-4431
Abstract 4431 The European Treatment Outcome Study (EUTOS) is register based international investigation started in June 2007. [1] The aim is to study the epidemiology of CML and to gain insight into the ‘real world’ treatment of patients with CM
Autor:
Elena Fleishman, Larisa Fechina, Rolf Marschalek, Anatoly Kustanovich, Sokova Oi, Claus Meyer, Liudmila Martynenko, Irina Martynkevich, Grigory Tsaur, Alena Volochnik, Olga Plekhanova, Tatyana Gindina, Alexander Popov, Tatyana Riger, Anna Kazakova, Yulia Olshanskaya, Vanik A. Ovsepyan, Elena Matveeva, Egor Shorikov, Leonid Saveliev
Publikováno v:
Blood. 120:2498-2498
Abstract 2498 Background. MLL gene rearrangements are associated with unfavorable outcome in infant acute lymphoblastic leukemia (ALL) and have intermediate prognosis in infant acute myeloid leukemia (AML). Application of fluorescence in-situ hybridi